General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0PHKMG
ADC Name
TORL-4-500
Synonyms
TORL 4-500
   Click to Show/Hide
Organization
TORL Biotherapeutics LLC
Drug Status
Phase 1
Indication
In total 1 Indication(s)
Hepatocellular carcinoma [ICD11:2C12]
Investigative
Antibody Name
Undisclosed
Antigen Name
Undisclosed
Payload Name
Undisclosed
Linker Name
Undisclosed

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.